# Title
Effect O
of O
homocysteine B-Chemical
and O
homocystine B-Chemical
on O
platelet O
and O
vascular O
arachidonic B-Chemical
acid I-Chemical
metabolism. O

# Abstract
Normal O
hemostasis O
depends O
in O
part O
on O
the O
balance O
achieved O
between O
proaggregatory O
and O
prothrombotic O
platelet O
thromboxane B-Chemical
A2, I-Chemical
measured O
as O
its O
stable O
end-product O
thromboxane B-Chemical
B2 I-Chemical
(TXB2), B-Chemical
and O
vascular O
prostacyclin B-Chemical
(PGI2), B-Chemical
which O
inhibits O
platelet B-Disease
aggregation I-Disease
and O
is O
antithrombotic. O
Cystathionine-beta-synthase B-Disease
deficiency I-Disease
is O
characterized O
by O
a O
high O
frequency O
of O
thromboembolic B-Disease
disease. I-Disease
We O
therefore O
studied, O
in O
vitro, O
the O
effects O
of O
homocysteine B-Chemical
and O
related O
compounds O
on O
platelet O
TXB2 B-Chemical
and O
vascular O
PGI2 B-Chemical
formation. O
In O
paired O
samples O
of O
platelet O
rich O
plasma, O
which O
had O
been O
preincubated O
with O
L-homocystine B-Chemical
(1 O
mM), O
mean O
production O
of O
the O
two O
platelet O
cyclooxygenase O
products, O
TXB2 B-Chemical
and O
12-hydroxy-5, B-Chemical
8,10-heptadecatrienoic I-Chemical
acid I-Chemical
increased O
significantly O
from O
control O
levels O
[13.6% O
+ O
- O
1.9 O
to O
19.8% O
+ O
- O
2.1 O
(P O
less O
than O
0.02) O
TXB2 B-Chemical
and O
29.8% O
+ O
- O
4.2 O
to O
39.4% O
+ O
- O
4.1 O
(P O
less O
than O
0.01) O
HHT]. B-Chemical
In O
the O
presence O
of O
D,L-homocysteine B-Chemical
(1 O
mM), O
mean O
TXB2 B-Chemical
and O
12-hydroxy-5,8,10-heptadecatrienoic B-Chemical
acid I-Chemical
production O
was O
also O
significantly O
increased O
[12.7% O
+ O
- O
1.5 O
to O
16.9% O
+ O
- O
1.5 O
(P O
less O
than O
0.01) O
TXB2 B-Chemical
and O
27% O
+ O
- O
4 O
to O
31% O
+ O
- O
4.1 O
(P O
less O
than O
0.02) O
HHT]. B-Chemical
Cystine, B-Chemical
cysteine, B-Chemical
or O
methionine B-Chemical
(1 O
mM) O
did O
not O
have O
similar O
effects O
in O
this O
test O
system. O
Homocysteine B-Chemical
and O
homocystine B-Chemical
were O
without O
effect O
on O
the O
synthesis O
of O
vascular O
PGI2 B-Chemical
by O
umbilical O
artery O
segments O
[control, O
0.22 O
+ O
- O
0.03 O
to O
0.21 O
+ O
- O
0.03 O
ng O
mg O
with O
D,L-homocysteine B-Chemical
and O
0.20 O
+ O
- O
0.04 O
control O
to O
0.19 O
+ O
- O
0.04 O
ng O
mg O
with O
D,L-homocystine]. B-Chemical
A O
homocyst(e)ine-induced O
increase O
in O
platelet O
thromboxane B-Chemical
production O
in O
the O
absence O
of O
an O
increase O
in O
vascular O
prostacyclin, B-Chemical
if O
present O
in O
vivo, O
may O
contribute O
to O
the O
vascular B-Disease
thromboses I-Disease
characteristic O
of O
human B-Species
homocystinemias B-Disease
(homocystinurias). B-Disease